Module 7: Gastrointestinal System Flashcards
Liver inflammation
Etiology
* viral infection
* toxins
* drugs
* other (immune mediated
Hepatitis
Etiology
* Hepatitis A Virus (most common viral hepatitis worldwide)
Pathogenesis
* fecal-oral transmission, virus is directly cytopathic to the liver but does not lead to
cirrhosis
Signs
* jaundice (after 1-2 weeks) (due to intrahepatic cholestasis)
o inc. conjugated bilirubin
* > pale stools
* > dark urine
* +/- hepatomegaly
* +/- splenomegaly
* +/- tender lymphadenopathy
* rarely - hepatic encephalopathy & death
HEPATITIS A VIRUS (Acute)
Very similar to Hep A but high mortality in pregnancy (20% > DIC in 3rd Trimester)
Etiology
* Hepatitis E virus (a herpes virus)
Pathogenesis
* Virus is directly cytopathic to the liver
Clinical Features
* fecal-oral transmission (incl. vectors: dogs/pigs/rodents
Prognosis
* 1-2% mortality (from fulminant hepatic failure)
* 20% mortality in pregnancy (from DIC in 3rd trimester)
HEPATITS E VIRUS (Acute)
- transmission via parenteral route or equivalent
- vertical transmission
- occurs during 3rd trimester or early post-partum
*HBsAg +ve, HBeAg +ve mothers ––> 90% of infants infected
*HBsAg +ve, anti-HBe +ve mothers ––> 10-15% infected
* give HBIG and full HBV vaccination to newborns of HBsAg +ve mothers (90% effective)
- incubation period: 6 weeks to 6 months
- infectivity: during HBsAg positivity
HEPATITIS B VIRUS (HBV) Acute and Chronic
Transmission is chiefly parenteral
*Transfusions (HCV is the most common cause of post-transfusion hepatitis)
*IV drugs use
*Sexual transmission occurs but risk is less than with HBV
*40% of cases have no risk factors
- Clinical incubation period: 5-10 weeks
- AST and ALT levels fluctuate (unlike Hep A or B)
- More than half progress to chronic liver disease
Treatment:
*no accepted vaccine
HEPATITIS C VIRUS (HCV) Chronic
Infectious only in the presence of HBV because HBV surface antigens are required for replication.
Transmission: Close personal contact or Transmission of blood
Types of Infection: Coinfection and Superinfection
Prevention: HBV vaccine
HEPATITIS D (HDV) Acute and Chronic
Fecal-oral transmission occurring in epidemics in Asia, Africa, Central America
* most have mild disease, but in 3rd trimester of pregnancy 10-
20% have fulminant liver failure
* serology: anti-HEV
Prevention
* no vaccine available
HEPATITIS E VIRUS (HEV) Acute
Name the 5 Drug induced liver disease / Drug induced hepatitis
Clue: ACE, CHL,INH,METH,AMI
Acetaminophen
Chlorpromazine
Isoniazid
Methotrexate
Amiodarone
Can cause same histology and clinical outcome as alcoholic hepatitis
Amiodarone
May rarely cause cirrhosis, especially in the presence of obesity, diabetes, alcoholism
Scarring develops without symptoms or changes in liver enzymes, therefore biopsy may be needed in long-term treatment
Methotrexate
20% develop elevated transaminases but < 1% develop clinically
significant disease
Susceptibility to injury increases with age
INH (Isoniazid)
Cholestasis in 1% after 4 weeks; often with fever, rash, jaundice, pruritus and eosinophilia
Chlorpromazine
Metabolized by hepatic cytochrome P450 system
* can cause fulminant hepatic failure
* hepatic necrosis resulting in increased
aminotransferases, jaundice, possibly hepatic encephalopathy, acute renal failure, death
Acetaminophen
Type of Stone?
(80%) = mixed (> 70% cholesterol by weight),
radiolucent
Risk factors:
* Female, fat, fertile, forties
* North American First Nations peoples have
highest incidence
* diabetes mellitus (DM), pancreatitis
* malabsorption, terminal ileal resection or disease
(e.g. inflammatory bowel diseases)
Cholesterol
(20%), may be radio-opaque (Seen in xray)
Pigment stones
What Pigment stones are composed of unconjugated bilirubin, calcium, bile
acids?
smooth green/black to brown
What Pigment stones are associated with cirrhosis, chronic hemolytic states?
black pigment stones
What Pigment stones are associated with bile stasis, (biliary strictures, dilatation and biliary infection (Clonorchis sinensis)?
Calcium bilirubinate stones